部份中文Vitafol One处方资料（仅供参考）
治疗类别名称
高热量输液多种维生素
商標名
Daimedin・Multi
组成
Daimejin多种维生素
包含在一个小瓶下列成分，数量。
活性成分
盐酸氯化硫胺素
核黄素磷酸酯钠
（核黄素
盐酸吡哆醇
氰钴胺素
烟酰胺
叶酸
泛醇
（泛酸
生物素
抗坏血酸
维生素A棕榈酸酯
钙化醇
生育酚乙酸酯
植物甲萘醌为3mg
5.08mg
4毫克）
4mg
10微克
40毫克
0.4mg
14.04mg
15mg）
0.1mg
100毫克
3300维他命A单元
10微克
15mg
2mg
添加剂山梨酯80
麦芽糖
pH调节剂60毫克
50毫克
配方的性质
在暗黄色的质量与性能发红，有异味，是吸湿的。
pH为4.5〜5.5（溶于注射用水3ml）中
渗透压比1.0-1.4（生理盐水之比）
（溶于注射用水5mL）中
操作注意事项
为了避免被细菌污染，使用后残留的液体部分是，你不要使用。
稳定性试验
在结果的最终包装形式长期储存试验（10℃，20个月），Daimejin多注意被证实是一个18个月的规定的条件下稳定。
适应病症
口服，补充维生素的情况下肠内营养管别无选择，只能依靠非或不足的高热量静脉营养
用法用量
这种药物溶解在一种高热量静脉营养输液，静脉滴注。
剂量一般是和成人每日1瓶。此外，增加或减少取决于患者的年龄和症状。
包装规格
10瓶
生产商
日医工株式会社

Therapeutic category name
High-calorie infusion multivitamin
Brand Name
Daimejin multi-Note
composition
Daimejin multi-Note
Containing the following ingredients, quantity in one vial.
Contraindication
Patients with a history of hypersensitivity to the drug or the drug ingredients
Hemophilia patients [for panthenol containing]
Efficacy or effect
Oral, vitamin supplementation in the case where the enteral tube nutrition have no choice but to rely on non or insufficient high-calorie intravenous nutrition
This drug was dissolved in a high-calorie intravenous nutrition infusion, intravenous drip infusion.
Dose is usually, and adult day 1 bottle.
It should be noted that, to increase or decrease depending on the patient's age and symptoms.
Careful administration
Hypercalcemia patients (blood, do the urine test, that to stop the administration if any abnormality is observed.) [For the ergocalciferol containing]
Patients with renal failure [side effects may appear strong]
Or his parents, brother to bronchial asthma, rash, [there is that side effects of hypersensitivity, etc. may occur strongly] patients with a predisposition to allergies to urticaria, etc.
Patients with a history of drug hypersensitivity
Pregnant women (see section "pregnant women, maternal, administration to nursing mothers, etc.")
Newborn, low birth weight babies, infants, toddlers and children (see section "administration to the children, etc.")
Clinically significant adverse reactions
Shock, anaphylactic-like symptoms (frequency unknown)
Shock, because it may cause anaphylaxis-like symptoms, carefully monitored, if the drop in blood pressure, impaired consciousness, dyspnea, cyanosis, nausea, chest in agony, facial flushing, itching, sweating, etc. appeared immediately discontinue administration and take appropriate action
http://www.info.pmda.go.jp/go/pack/3179515F1030_1_09/